About

Editor's emulsion 1st Feb 2018

Editor's emulsion 1st Feb 2018


Greetings!

 

The next time you buy something, think twice before holding the receipt generated on thermal paper. There is a high chance you may be exposing yourself to an endocrine disrupting chemical — Bisphenol-A (BPA). Read more on this hazardous hormone disrupting chemical that we, unknowingly, push into our system in our daily lives in our PSM India capsule and FAQ section.

 

There has been lots happening around the efficacy of drugs in our country lately. Be it the drugs body setting up a panel to review safety of FDCs or Health policy aiming at comprehensive healthcare for all; ensuring pharma cos do stability tests for all drugs or re-inspecting their manufacturing plants; corporate hospitals starting to report ADRs or monitoring retail drug supplies to patients; it’s all been covered in this issue of The Prescription. Hope you enjoy reading them as much as we did collating them for you.

 

Growth in the development of rare disease medicines has helped boost the number of new drugs approved in both the United States and the European Union. US saw a 21-year high of 46 new medicines being approved by the US Food and Drug Administration (FDA) in 2017, more than double the number approved the previous year. In the EU 92 new drugs were approved, up from 81 the year before. Our Global Injections carries more details on this while also including drug alerts and global acts and regulations on medicines.

 

We constantly endeavour not only to reach to you important information from the health and medicine world but also to create a connect with consumers all over. We welcome articles and write ups from our readers and are glad to place them under the section titled Subscriber’s Symptoms. This issue covers an informative contribution on What Supplements Scientists Use and Why?

 

Do not hesitate to mail your comments on this edition to help us improve further. We appreciate your support and trust in us and are happy to have you as our loyal reader.

Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@safemedicinesindia.in

 

The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions has gladly kicked off with many of you sharing your experience with me on mail. Please feel free to Post your pics on our facebook wall or chirp it on our twitter handle too. Keep reaching out.

 

Stay Healthy. Stay Protected.

 

Pooja Khaitan

Editor-in-Chief,

The Prescription